MTP

Midatech Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.050
+0.050
+2.50%
After Hours: 2.060 +0.01 +0.49% 19:53 08/07 EDT
OPEN
2.100
PREV CLOSE
2.000
HIGH
2.150
LOW
2.020
VOLUME
276.01K
TURNOVER
--
52 WEEK HIGH
8.50
52 WEEK LOW
0.8620
MARKET CAP
24.83M
P/E (TTM)
-0.1241
1D
5D
1M
3M
1Y
5Y

MTP News

More
Midatech Pharma Says UK Placing to Raise £5M; 18.5M Shares Priced @ £0.27/Share; Says Placing was Significantly Oversubscribed
Midatech Pharma PLC (Nasdaq: MTP) announces that it has raised £5.0 million (before expenses) by way of a placing to investors in the UK ("UK Placing") of 18,518,518 new ordinary shares of 0.1p each ("Placing Shares") at an issue price of £0.27
Benzinga · 07/27 09:35
INTC, NIO among premarket losers
Seeking Alpha · 07/24 12:24
Midatech terminates formal sale process
Midatech (NASDAQ:MTP) has terminated the formal sale process initiated on April 20. The sale procedure granted dispensations from Rule 2 of the Takeover Co
seekingalpha · 07/23 15:32
Mid-Morning Market Update: Markets Down; AT&T Earnings Beat Estimates
Following the market opening Thursday, the Dow traded down 0.26% to 26,936.51 while the NASDAQ fell 0.11% to 10,692.02. The S&P also fell, dropping 0.04% to 3,274.73.
Benzinga · 07/23 14:13
The Daily Biotech Pulse: Midatech Shelves Sale Plan, G1 Therapeutics Out-Licenses, Entera Bio Jumps On Survey Results
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22)
Benzinga · 07/23 12:25
A Peek Into The Markets: US Stock Futures Up Ahead Of Earnings, Jobless Claims Data
Pre-open movers
Benzinga · 07/23 10:20
Midatech Pharma Announces Formal Sale Process Termination
Midatech (Nasdaq: MTP) announces it has terminated the formal sale process initiated by the Company on 20 April 2020.
Benzinga · 07/23 09:21
Mid-Morning Market Update: Markets Edge Higher; Thermo Fisher Scientific Tops Q2 Estimates
Following the market opening Wednesday, the Dow traded up 0.13% to 26875.29 while the NASDAQ rose 0.39% to 10722.03. The S&P also rose, gaining 0.24% to 3,264.96.
Benzinga · 07/22 14:16

Industry

Biotechnology & Medical Research
-0.18%
Pharmaceuticals & Medical Research
+0.08%

Hot Stocks

Symbol
Price
%Change

About MTP

Midatech Pharma PLC is a research and development biopharmaceutical company that is focused on commercializing and developing products in oncology and other therapeutic areas. The Company operates through Pipeline Research and Development segment. The Pipeline Research and Development segment seeks to develop products using the nanomedicine and sustained release technology platforms. The Company develops chemo therapeutics or new immune therapeutics, using its drug delivery technologies. Q-Sphera platform is the polymer microsphere technology is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months. Midasolve platform is its nanosaccharide technology is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumours. Midacore platform is the gold nanoparticle technology that is used for targeting sites of disease at the nanoscale.
More

Webull offers kinds of Midatech Pharma PLC-ADR stock information, including NASDAQ:MTP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MTP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MTP stock methods without spending real money on the virtual paper trading platform.